Acute Coronary Syndromes

Acute coronary syndrome (ACS) is most commonly caused by a heart attack (myocardial infarction) where blood flow to the heart is suddenly blocked. This is usually caused by a blood clot from a ruptured coronary artery atherosclerotic plaque. Other causes include spontaneous coronary artery dissection (SCAD), which most commonly occurs in women. ACS is usually treated in a cath lab with angioplasty and the placement of a stent to prop the vessel open.

RSS icon

What to expect at ACC 2018

The name of the game at this year’s American College of Cardiology (ACC) Scientific Sessions is innovation. Between thousands of handpicked poster sessions, 20 late-breakers and a handful of featured clinical research trials, presenters will focus on the latest in cutting-edge cardiology, ACC leaders said at a Wednesday, Feb. 21 briefing.

Combination of AI, eye images could predict cardiovascular disease

Google researchers are testing an artificial intelligence (AI) platform that aims to predict a person’s risk of heart attack or stroke by examining images of the patient’s retina. They hope this method can eventually replace more invasive techniques for predicting cardiovascular disease.

Why is it more difficult to ID heart attacks in women?

Young women presenting to the hospital with acute myocardial infarction (AMI) report more non-chest related symptoms than men. Perhaps as a result of this complexity, patients and physicians are less likely to perceive those early symptoms as heart-related, according to a study published Feb. 19 in Circulation.

Meta-analysis: Combination of DOACs, antiplatelets only favorable for STEMI

Direct oral anticoagulants (DOACs) provide additional benefit to antiplatelet therapy following acute coronary syndrome (ACS)—but only for ST-segment elevation myocardial infarction (STEMI)—according to a meta-analysis in JAMA Cardiology.

Blood test after heart attack unveils another prognostic biomarker

A plasma test to determine the maximum density of a blood clot and how long it takes to break down could help identify heart attack patients at increased risk for cardiovascular death or another myocardial infarction (MI), according to a study published Jan. 29 in the European Heart Journal.

Routine tests could be missing 2/3 of heart attack diagnoses

Routine medical tests could be missing as many as two-thirds of heart attack diagnoses, researchers reported at CMR 2018, an annual conference dedicated to cardiac magnetic resonance imaging in Barcelona, Spain.

Thumbnail

Meta-analysis finds omega-3 supplements provide little benefit

Omega-3 supplements may not protect a patient from heart disease or vascular events, according to a meta-analysis published in JAMA Cardiology.

High doses of vitamin D shown to restore cardiovascular system post-heart attack

The benefits of vitamin D aren’t limited to improving bone health and fighting disease—the “sunshine vitamin” has now been shown to help restore damage to heart patients’ cardiovascular systems, according to research published in the International Journal of Nanomedicine this week.

Displaying 585 - 592 of 665

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.